Prof. Andrew Hopkins was named as the winner of the 3rd Capps Green Zomaya Award in Medicinal or Computational Chemistry at a conference in Hertfordshire last week.
Prof. Hopkins was honoured for his for his work on computer-aided drug discovery at Pfizer, UK. He has developed new methodologies for assessing drug targets for their ‘druggability’, leading to increases in the success rates of high-throughput screening procedures. With his colleagues at Pfizer, he has developed the concept of ‘ligand efficiency’ in drug design (Nature (2004), 432 (7019), 855-861). These techniques have been applied to a number of different drug targets, including the search for non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties (J.Med.Chem. (2004), 47(24), 5923-5936).
Last year Prof. Hopkins took the Chair of Medicinal Informatics in the Division of Biological Chemistry and Drug Discovery at the College of Life Sciences, University of Dundee. Professor Hopkins was presented with the Award and he delivered the 3rd Capps Green Zomaya Memorial Lecture entitled ‘The Efficiency of Choice’at the 19th Symposium on Medicinal Chemistry in Eastern England which was held at the Fielder Centre in the University of Hertfordshire on April 24th, 2008.
Prof. Hopkins said, "I am both honoured and humbled to receive this RSC medal. It is very encouraging to be recognised by the chemistry community for the impact some of our ideas have made."
The bienniel Capps Green Zomaya Award is in memory of three medicinal chemists, Nigel Capps, Richard Green and Alex Zomaya who died in a flying accident in 2001. The Award recognises outstanding contributions made to drug discovery by medicinal chemists before the age of 40. The Award is given under the auspices of the Royal Society of Chemistry and is administered by the Capps Green Zomaya Memorial Trust (registered charity No. 1116496).